Dr. Manal El-Sayed (Cairo, Egypt) is Professor of Pediatrics, director of the clinical research center (MASRI-CRC) and co-supervisor of the viral hepatitis treatment center at the Faculty of Medicine, Ain Shams University.
Dr El-Sayed is a founding member of the Egyptian National Committee for Control of Viral Hepatitis (NCCVH) since 2006. She contributed to the establishment of a nationwide network of more than 100 specialized liver centers that provided interferon therapy and direct-acting antiviral agents for the treatment of more than 3 million HCV patients. Manal collaborated on the development of the national action plan for prevention and control of viral hepatitis published in 2014 with representatives from WHO, U.S. CDC, Pasteur Institute, and national stakeholders. In addition to co-supervising the nationwide mass screening program for adults and children reaching so far more than 59 million people.
Manal is also secretary-general of the Egyptian Liver Care Society, an NGO offering financial assistance to patients receiving hepatitis treatment or liver transplants. She authored and co-authored numerous journal articles on hepatitis, and participated in the development of WHO’s global HBV, HCV and diagnostic guidelines. Between 2011-2015, Manal was Vice-Chair of WHO’s Technical Advisory Group for Prevention and Control of Viral Hepatitis in Egypt and has been a member of the Global Accelerator for Pediatric Formulations (GAP-f) since December 2016.
She has been a board member of the EASL International Liver Foundation since January 2018. In addition to co-organising and co-chairing numerous international meetings on viral hepatitis and liver disease in Europe and Africa.